Correlation Between Lyra Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Lyra Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Mereo BioPharma.
Diversification Opportunities for Lyra Therapeutics and Mereo BioPharma
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyra and Mereo is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Mereo BioPharma. In addition to that, Lyra Therapeutics is 2.54 times more volatile than Mereo BioPharma Group. It trades about -0.07 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.05 per unit of volatility. If you would invest 405.00 in Mereo BioPharma Group on August 25, 2024 and sell it today you would lose (33.00) from holding Mereo BioPharma Group or give up 8.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Mereo BioPharma Group
Performance |
| Timeline |
| Lyra Therapeutics |
| Mereo BioPharma Group |
Lyra Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Mereo BioPharma
The main advantage of trading using opposite Lyra Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
| Mereo BioPharma vs. Eliem Therapeutics | Mereo BioPharma vs. HCW Biologics | Mereo BioPharma vs. Scpharmaceuticals | Mereo BioPharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |